It has been reported that, in DSS-induced colitis models, ginger-derived nanoparticles were found to be predominantly absorbed by intestinal epithelial and immune cells, decreasing pro-inflammatory cytokines (TNF-α, IL-6), and improving barrier function (Zhang et al., 2016). The gene discussed is TNF; the disease is colitis.